US Stock MarketDetailed Quotes

ITOS ITeos Therapeutics

Watchlist

18.030
-0.060-0.33%

Close May 21 16:00 ET

18.030
0.0000.00%

Post 16:20 ET

651.30MMarket Cap-4769P/E (TTM)

ITeos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-22.01%-32.4M

6.69%-103.76M

49.34%-13.77M

-14.12%-33.89M

2.56%-29.55M

-10.64%-26.56M

-121.67%-111.19M

53.80%-27.17M

-104.91%-29.7M

-66.10%-30.32M

Net income from continuing operations

-145.75%-38.22M

-216.54%-112.64M

-249.37%-30.55M

-3,353.28%-32.24M

-709.67%-34.3M

-122.35%-15.55M

-54.95%96.65M

-88.94%20.45M

-98.58%991K

121.26%5.63M

Depreciation and amortization

36.94%304K

11.83%898K

1.79%227K

9.27%224K

15.38%225K

23.33%222K

33.17%803K

47.68%223K

16.48%205K

30.00%195K

Other non cash items

-150.00%-1K

----

0.00%2K

-16.67%10K

50.00%3K

0.00%2K

Change In working capital

106.98%990K

96.15%-8.8M

122.21%11.55M

82.88%-6.27M

100.24%101K

85.52%-14.18M

-180.40%-228.49M

79.02%-52.01M

-106.89%-36.62M

-968.50%-41.91M

-Change in receivables

-78.09%384K

-172.50%-7.32M

-160.62%-2.3M

-249.25%-3.04M

-545.42%-3.74M

-77.38%1.75M

192.72%10.1M

164.71%3.79M

4.82%-869K

81.64%-579K

-Change in prepaid assets

-209.57%-252K

-68.81%184K

737.85%1.84M

32.37%-2.36M

-81.49%472K

-87.29%230K

105.00%590K

94.75%-288K

45.47%-3.48M

718.93%2.55M

-Change in payables and accrued expense

114.61%647K

43.04%8.38M

33,440.63%10.67M

93.17%-768K

110.50%2.91M

-109.88%-4.43M

-52.14%5.86M

-101.08%-32K

-1,281.60%-11.24M

-442.54%-27.68M

-Change in other working capital

101.80%211K

95.90%-10.04M

102.43%1.35M

99.47%-111K

102.84%460K

92.29%-11.74M

-183.16%-245.03M

76.83%-55.48M

-103.91%-21.03M

-5,340.13%-16.19M

Cash from discontinued investing activities

Operating cash flow

-22.01%-32.4M

6.69%-103.76M

49.34%-13.77M

-14.12%-33.89M

2.56%-29.55M

-10.64%-26.56M

-121.67%-111.19M

53.80%-27.17M

-104.91%-29.7M

-66.10%-30.32M

Investing cash flow

Cash flow from continuing investing activities

-119.60%-69.6M

116.29%72.66M

113.83%61.56M

21,712.38%22.69M

4,011.09%20.1M

-9,712.38%-31.69M

-35,814.81%-446.06M

-276,372.05%-445.12M

80.26%-105K

-12.23%-514K

Net PPE purchase and sale

-694.12%-945K

-216.20%-2.97M

-1,093.16%-1.4M

-804.82%-751K

-36.99%-700K

47.58%-119K

20.58%-938K

27.78%-117K

84.34%-83K

-27.43%-511K

Net investment purchase and sale

-117.43%-68.66M

117.02%75.72M

114.15%62.97M

--23.53M

--20.8M

---31.58M

---445M

--0

Net other investing changes

----

17.50%-99K

-1,700.00%-16K

----

-96.72%-120K

0.00%1K

-1,000.00%-22K

94.74%-3K

Cash from discontinued investing activities

Investing cash flow

-119.60%-69.6M

116.29%72.66M

113.83%61.56M

21,712.38%22.69M

4,011.09%20.1M

-9,712.38%-31.69M

-35,814.81%-446.06M

-276,372.05%-445.12M

80.26%-105K

-12.23%-514K

Financing cash flow

Cash flow from continuing financing activities

-96.19%22K

-43.90%1.11M

-77.66%307K

1,100.00%10K

-21.58%218K

73.57%578K

-45.78%1.98M

-41.68%1.37M

-100.23%-1K

42.56%278K

Proceeds from stock option exercised by employees

-96.19%22K

20.32%1.11M

-2.54%307K

1,100.00%10K

-21.58%218K

73.57%578K

-68.57%925K

-80.79%315K

-100.23%-1K

42.56%278K

Net other financing activities

----

47.91%1.06M

----

Cash from discontinued financing activities

Financing cash flow

-96.19%22K

-43.90%1.11M

-77.66%307K

1,100.00%10K

-21.58%218K

73.57%578K

-45.78%1.98M

-41.68%1.37M

-100.23%-1K

42.56%278K

Net cash flow

Beginning cash position

-11.78%251.45M

-66.42%285.04M

-72.84%204.4M

-72.67%216.48M

-72.63%225.6M

-66.42%285.04M

152.29%848.84M

-16.38%752.47M

161.37%792.15M

156.37%824.28M

Current changes in cash

-76.83%-101.98M

94.60%-29.99M

110.21%48.1M

62.46%-11.19M

69.81%-9.23M

-140.38%-57.67M

-207.70%-555.27M

-731.70%-470.92M

-104.93%-29.8M

-65.02%-30.56M

Effect of exchange rate changes

-44.21%-2.55M

57.75%-3.6M

-130.05%-1.05M

90.94%-895K

107.13%112K

-214.56%-1.77M

-168.45%-8.53M

-37.18%3.49M

-22.31%-9.88M

-2,444.78%-1.57M

End cash Position

-34.88%146.92M

-11.78%251.45M

-72.84%204.4M

-72.67%216.48M

-72.63%225.6M

-66.42%285.04M

-16.38%752.47M

161.37%792.15M

Free cash flow

-25.01%-33.35M

4.82%-106.72M

44.44%-15.16M

-16.33%-34.64M

1.90%-30.25M

-10.09%-26.67M

-121.90%-112.13M

53.73%-27.29M

-104.93%-29.78M

-65.27%-30.83M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-22.01%-32.4M	6.69%-103.76M	49.34%-13.77M	-14.12%-33.89M	2.56%-29.55M	-10.64%-26.56M	-121.67%-111.19M	53.80%-27.17M	-104.91%-29.7M	-66.10%-30.32M
Net income from continuing operations	-145.75%-38.22M	-216.54%-112.64M	-249.37%-30.55M	-3,353.28%-32.24M	-709.67%-34.3M	-122.35%-15.55M	-54.95%96.65M	-88.94%20.45M	-98.58%991K	121.26%5.63M
Depreciation and amortization	36.94%304K	11.83%898K	1.79%227K	9.27%224K	15.38%225K	23.33%222K	33.17%803K	47.68%223K	16.48%205K	30.00%195K
Other non cash items	-150.00%-1K	----	----	----	----	0.00%2K	-16.67%10K	50.00%3K	50.00%3K	0.00%2K
Change In working capital	106.98%990K	96.15%-8.8M	122.21%11.55M	82.88%-6.27M	100.24%101K	85.52%-14.18M	-180.40%-228.49M	79.02%-52.01M	-106.89%-36.62M	-968.50%-41.91M
-Change in receivables	-78.09%384K	-172.50%-7.32M	-160.62%-2.3M	-249.25%-3.04M	-545.42%-3.74M	-77.38%1.75M	192.72%10.1M	164.71%3.79M	4.82%-869K	81.64%-579K
-Change in prepaid assets	-209.57%-252K	-68.81%184K	737.85%1.84M	32.37%-2.36M	-81.49%472K	-87.29%230K	105.00%590K	94.75%-288K	45.47%-3.48M	718.93%2.55M
-Change in payables and accrued expense	114.61%647K	43.04%8.38M	33,440.63%10.67M	93.17%-768K	110.50%2.91M	-109.88%-4.43M	-52.14%5.86M	-101.08%-32K	-1,281.60%-11.24M	-442.54%-27.68M
-Change in other working capital	101.80%211K	95.90%-10.04M	102.43%1.35M	99.47%-111K	102.84%460K	92.29%-11.74M	-183.16%-245.03M	76.83%-55.48M	-103.91%-21.03M	-5,340.13%-16.19M
Cash from discontinued investing activities
Operating cash flow	-22.01%-32.4M	6.69%-103.76M	49.34%-13.77M	-14.12%-33.89M	2.56%-29.55M	-10.64%-26.56M	-121.67%-111.19M	53.80%-27.17M	-104.91%-29.7M	-66.10%-30.32M
Investing cash flow
Cash flow from continuing investing activities	-119.60%-69.6M	116.29%72.66M	113.83%61.56M	21,712.38%22.69M	4,011.09%20.1M	-9,712.38%-31.69M	-35,814.81%-446.06M	-276,372.05%-445.12M	80.26%-105K	-12.23%-514K
Net PPE purchase and sale	-694.12%-945K	-216.20%-2.97M	-1,093.16%-1.4M	-804.82%-751K	-36.99%-700K	47.58%-119K	20.58%-938K	27.78%-117K	84.34%-83K	-27.43%-511K
Net investment purchase and sale	-117.43%-68.66M	117.02%75.72M	114.15%62.97M	--23.53M	--20.8M	---31.58M	---445M	---445M	--0	--0
Net other investing changes	----	17.50%-99K	-1,700.00%-16K	----	----	----	-96.72%-120K	0.00%1K	-1,000.00%-22K	94.74%-3K
Cash from discontinued investing activities
Investing cash flow	-119.60%-69.6M	116.29%72.66M	113.83%61.56M	21,712.38%22.69M	4,011.09%20.1M	-9,712.38%-31.69M	-35,814.81%-446.06M	-276,372.05%-445.12M	80.26%-105K	-12.23%-514K
Financing cash flow
Cash flow from continuing financing activities	-96.19%22K	-43.90%1.11M	-77.66%307K	1,100.00%10K	-21.58%218K	73.57%578K	-45.78%1.98M	-41.68%1.37M	-100.23%-1K	42.56%278K
Proceeds from stock option exercised by employees	-96.19%22K	20.32%1.11M	-2.54%307K	1,100.00%10K	-21.58%218K	73.57%578K	-68.57%925K	-80.79%315K	-100.23%-1K	42.56%278K
Net other financing activities	----	----	----	----	----	----	47.91%1.06M	----	----	----
Cash from discontinued financing activities
Financing cash flow	-96.19%22K	-43.90%1.11M	-77.66%307K	1,100.00%10K	-21.58%218K	73.57%578K	-45.78%1.98M	-41.68%1.37M	-100.23%-1K	42.56%278K
Net cash flow
Beginning cash position	-11.78%251.45M	-66.42%285.04M	-72.84%204.4M	-72.67%216.48M	-72.63%225.6M	-66.42%285.04M	152.29%848.84M	-16.38%752.47M	161.37%792.15M	156.37%824.28M
Current changes in cash	-76.83%-101.98M	94.60%-29.99M	110.21%48.1M	62.46%-11.19M	69.81%-9.23M	-140.38%-57.67M	-207.70%-555.27M	-731.70%-470.92M	-104.93%-29.8M	-65.02%-30.56M
Effect of exchange rate changes	-44.21%-2.55M	57.75%-3.6M	-130.05%-1.05M	90.94%-895K	107.13%112K	-214.56%-1.77M	-168.45%-8.53M	-37.18%3.49M	-22.31%-9.88M	-2,444.78%-1.57M
End cash Position	-34.88%146.92M	-11.78%251.45M	-11.78%251.45M	-72.84%204.4M	-72.67%216.48M	-72.63%225.6M	-66.42%285.04M	-66.42%285.04M	-16.38%752.47M	161.37%792.15M
Free cash flow	-25.01%-33.35M	4.82%-106.72M	44.44%-15.16M	-16.33%-34.64M	1.90%-30.25M	-10.09%-26.67M	-121.90%-112.13M	53.73%-27.29M	-104.93%-29.78M	-65.27%-30.83M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall